Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus
Carcinoma, Non-Small-Cell Lung
Our results provide a benchmark against which new treatment regimens can be evaluated. Control of locoregional disease remains the major challenge in treating lung cancers of the superior sulcus. The potential benefit of preoperative chemotherapy or chemoradiotherapy must be assessed by whether it leads to higher rates of complete resection and a lower risk of local relapse.